Ruthenium (Ru) complexes are known for their promising anticancer activity presumably
due to octahedral coordination geometry, slow ligand exchange rate, the range of different …

Coordination compounds [Ru (NO) Ln] containing an electro-active metal and potentially
non-innocent ligands NO (and L) can have ground state electronic structures formulated as …

New Schiff base ligand L derived from the condensation reaction of 2-amino-3-
formylchromone with (R)-2-amino-2-phenylethanol was synthesized and characterized …

Indole thiosemicarbazone ligands were prepared from indole-3-carboxaldehyde and N-(un)
substituted thiosemicarbazide. The Ru (η6-p-cymene) complexes [Ru (η6-p-cymene)(HL1) …

Cu (II) complexes of three tridentate ligands, L1, L2 and L3,[L1, N-((1H-imidazole-2-yl)
methyl)-2-(pyridine-2-yl) ethanamine; L2, N-((1-methyl-1H-imidazole-2-yl) methyl)-2 …

Copper (II) complexes [Cu (l-arg) 2](NO3) 2 (1) and [Cu (l-arg)(B) Cl] Cl (2− 5), where B is a
heterocyclic base, namely, 2, 2′-bipyridine (bpy, 2), 1, 10-phenanthroline (phen, 3) …

Incorporating water-insoluble nitric oxide (NO)-releasing molecules into biocompatible
vesicles may allow for the tunable control of NO release on a specific target site. In vesicles …

The transport and cytotoxicity of molybdenum-based drugs have been explained with the
concept of chemical transformation, a very important idea in inorganic medicinal chemistry …

To evaluate the biological preference of chiral drugs for molecular target DNA, new potential
metal-based chemotherapeutic agents 1–3 (a–c) of late 3d-transition metals derived from l …

Novel dipeptide complexes Cu (II)⋅ Val-Pro (1), Zn (II)⋅ Val-Pro (2), Cu (II)⋅ Ala-Pro (3) and
Zn (II)⋅ Ala-Pro (4) were synthesized and thoroughly characterized using different …